BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Decates TS, Velthuis PJ, Schelke LW, Lardy N, Palou E, Schwartz S, Bachour Y, Niessen FB, Nijsten T, Alijotas-Reig J. Increased risk of late-onset, immune-mediated, adverse reactions related to dermal fillers in patients bearing HLA-B*08 and DRB1*03 haplotypes. Dermatol Ther 2021;34:e14644. [PMID: 33300274 DOI: 10.1111/dth.14644] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Michel JC, Perenack JD, Chapple AG, Christensen BJ. Are Delayed Dermal Filler Granulomas More Common Since COVID-19? Journal of Oral and Maxillofacial Surgery 2022. [DOI: 10.1016/j.joms.2022.09.011] [Reference Citation Analysis]
2 López Pérez V. [Translated article] COVID-19 and Dermal Fillers: Should We Really Be Concerned? Actas Dermo-Sifiliográficas 2022. [DOI: 10.1016/j.ad.2022.08.013] [Reference Citation Analysis]
3 López Pérez V. COVID y rellenos faciales ¿realmente debemos preocuparnos? Actas Dermo-Sifiliográficas 2022. [DOI: 10.1016/j.ad.2022.05.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kalantari Y, Aryanian Z, Mirahmadi SM, Alilou S, Hatami P, Goodarzi A. A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles. J Cosmet Dermatol 2022. [PMID: 35534886 DOI: 10.1111/jocd.15071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N. Cutaneous adverse effects of the available COVID-19 vaccines. Clin Dermatol 2021;39:523-31. [PMID: 34518015 DOI: 10.1016/j.clindermatol.2021.04.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 44.0] [Reference Citation Analysis]
6 Owczarczyk-Saczonek A, Zdanowska N, Wygonowska E, Placek W. The Immunogenicity of Hyaluronic Fillers and Its Consequences. Clin Cosmet Investig Dermatol 2021;14:921-34. [PMID: 34295171 DOI: 10.2147/CCID.S316352] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Heydenrych I, De Boulle K, Kapoor KM, Bertossi D. The 10-Point Plan 2021: Updated Concepts for Improved Procedural Safety During Facial Filler Treatments. Clin Cosmet Investig Dermatol 2021;14:779-814. [PMID: 34276222 DOI: 10.2147/CCID.S315711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
8 Munavalli GG, Knutsen-Larson S, Lupo MP, Geronemus RG. Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation. JAAD Case Rep 2021;10:63-8. [PMID: 33681439 DOI: 10.1016/j.jdcr.2021.02.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 42.0] [Reference Citation Analysis]
9 Rice SM, Ferree SD, Mesinkovska NA, Kourosh AS. The art of prevention: COVID-19 vaccine preparedness for the dermatologist. Int J Womens Dermatol 2021;7:209-12. [PMID: 33457487 DOI: 10.1016/j.ijwd.2021.01.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 31.0] [Reference Citation Analysis]
10 Ikonnikova E, Manturova N, Kruglova L. COVID-19 and delayed inflammatory reactions to hyaluronic acid fillers: what we know about it? Plast khir 2021. [DOI: 10.17116/plast.hirurgia202103168] [Reference Citation Analysis]